Scientists hunt for clues to predict deadly clots

NCT ID NCT05548062

Ongoing Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study aims to identify factors that can predict which patients with a blood cancer called polycythemia vera are most at risk for dangerous blood clots. Researchers will observe 242 patients who are already receiving standard treatment for their condition. They will collect health data over three years to look for patterns that signal a higher risk of clots.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Alessandria, AL, 15121, Italy
Novartis Investigative Site

Ancona, AN, 60126, Italy
Novartis Investigative Site

Bari, BA, 70124, Italy
Novartis Investigative Site

Bologna, BO, 40138, Italy
Novartis Investigative Site

Como, CO, 22100, Italy
Novartis Investigative Site

Cosenza, CS, 87100, Italy
Novartis Investigative Site

Catania, CT, 95123, Italy
Novartis Investigative Site

Florence, FI, 50134, Italy
Novartis Investigative Site

Genova, GE, 16132, Italy
Novartis Investigative Site

Lecce, LE, 73100, Italy
Novartis Investigative Site

Tricase, LE, 73039, Italy
Novartis Investigative Site

Monza, MB, 20900, Italy
Novartis Investigative Site

Milan, MI, 20122, Italy
Novartis Investigative Site

Palermo, PA, 90127, Italy
Novartis Investigative Site

Palermo, PA, 90146, Italy
Novartis Investigative Site

Piacenza, PC, 29100, Italy
Novartis Investigative Site

Padova, PD, 35100, Italy
Novartis Investigative Site

Padova, PD, 35128, Italy
Novartis Investigative Site

Pisa, PI, 56124, Italy
Novartis Investigative Site

Parma, PR, 43126, Italy
Novartis Investigative Site

Reggio Calabria, RC, 89100, Italy
Novartis Investigative Site

Reggio Emilia, RE, 42123, Italy
Novartis Investigative Site

Roma, RM, 00161, Italy
Novartis Investigative Site

Roma, RM, 00168, Italy
Novartis Investigative Site

Roma, RM, 00189, Italy
Novartis Investigative Site

Pagani, SA, 84016, Italy
Novartis Investigative Site

Orbassano, TO, 10043, Italy
Novartis Investigative Site

Torino, TO, 10126, Italy
Novartis Investigative Site

Terni, TR, 05100, Italy
Novartis Investigative Site

Varese, VA, 21100, Italy
Novartis Investigative Site

Vicenza, VI, 36100, Italy
Novartis Investigative Site

Verona, VR, 37134, Italy
Novartis Investigative Site

Viterbo, VT, 01033, Italy
Novartis Investigative Site

Naples, 80131, Italy
Novartis Investigative Site

Naples, 80132, Italy

Conditions

Explore the condition pages connected to this study.

POLYCYTHEMIA VERA